Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Canadian researchers analyzed the reasons why people declined a nurse’s offer of PrEP.
Both Truvada and Descovy are highly effective and safe for most people taking PrEP, but the newer option has more cost barriers.
Researchers have called for revised treatment guidelines to address the higher risk of fracture in the HIV population.
Learn about the differences between these two HIV prevention options.
Plus: Tell your representatives to support the PrEP Access and Coverage Act. Here’s how.
This PrEP dosing strategy involves taking doses of Truvada only during the days surrounding sex.
Around 38,000 new HIV cases still occur each year, and more than 80% of people who could benefit from PrEP aren’t using it.
The U.S. Health Department launched Ready, Set, PrEP to provide the HIV prevention med at no cost.
New forms of treatment and PrEP and, hopefully, an at least partially effective vaccine will be key to fighting the epidemic in the 2020s.
An analysis of veterans seeking PrEP found that they often had to be extraordinarily persistent in their efforts to receive a prescription.
Rates of HIV acquisition were very low among people taking Descovy or Truvada, but Descovy had less effect on kidneys and bones.
The Food and Drug Administration approves once-daily Descovy for PrEP.
The integrase inhibitor–based HIV regimen was compared with dolutegravir-based regimens.
Hint: It’s not that Apicha’s HIV prevention campaign is too sexy.
However, serious kidney problems and bone fractures were rare among people taking either Descovy or Truvada for HIV prevention.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.